Table 3.
Status quo 2001 | Trend case 2008 | |||
---|---|---|---|---|
Exposure criterion: serum cotinine (ng/mL) | ≥0.05 | ≥0.10 | ≥0.05 | ≥0.10 |
RR of CHD due to passive smoking: 1.26 | ||||
Deaths | ||||
M | 27,700 | 17,700 | 20,900 | 11,900 |
SE | 800 | 700 | 800 | 600 |
Total MIs | ||||
M | 48,400 | 31,400 | 36,500 | 21,500 |
SE | 1,400 | 1,200 | 1,300 | 1,100 |
First MIs | ||||
M | 27,600 | 18,000 | 20,900 | 12,300 |
SE | 800 | 700 | 800 | 700 |
Total CHD events | ||||
M | 58,400 | 37,800 | 44,100 | 25,900 |
SE | 1,700 | 1,500 | 1,600 | 1,000 |
CHD treatment cost (million $ 2000 ) | ||||
Mean | 2,300 | 1,500 | 1,700 | 1,000 |
SE | 100 | 100 | 100 | 100 |
RR of CHD due to passive smoking: 1.65 | ||||
Deaths | ||||
M | 59,300 | 38,100 | 44,600 | 25,800 |
SE | 1,800 | 1,500 | 1,700 | 1,400 |
Total MIs | ||||
M | 105,100 | 69,100 | 79,300 | 46,300 |
SE | 3,400 | 2,800 | 3,000 | 2,500 |
First MIs | ||||
M | 61,800 | 40,700 | 46,700 | 27,300 |
SE | 2,000 | 1,600 | 1,800 | 1,500 |
Total CHD events | ||||
M | 126,000 | 82,100 | 95,000 | 55,100 |
SE | 4,000 | 3,300 | 3,600 | 2,900 |
CHD treatment cost (million $2000) | ||||
M | 5,000 | 3,300 | 3,700 | 2,200 |
SE | 200 | 100 | 100 | 100 |
CHD, coronary heart disease; MI, myocardial infarction; ng/mL, nanograms/milliliter; RR, relative risk